UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000042078
Receipt number R000034711
Scientific Title The feasibility of the new designed biliary metallic stent with distal tapering shape for the unresectable distal biliary malignancies: A pilot study
Date of disclosure of the study information 2020/10/11
Last modified on 2020/10/11 12:36:58

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The feasibility of the new designed biliary metallic stent with distal tapering shape for the unresectable distal biliary malignancies: A pilot study

Acronym

BULLET trial

Scientific Title

The feasibility of the new designed biliary metallic stent with distal tapering shape for the unresectable distal biliary malignancies: A pilot study

Scientific Title:Acronym

BULLET trial

Region

Japan


Condition

Condition

Unresectable distal malignant biliary obstruction

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To investigate the patency and safety of newly developed tapered Niti-S stent for distal malignancy biliary obstruction.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase II


Assessment

Primary outcomes

Stent malfunction and obstruction rate
Stent patency period

Key secondary outcomes

Median survival period
The incidence of adverse event


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Unresectable distal biliary malignant obstruction (regardless of primary disease)
2) Never received treatment with SEMS
3) Cases with expected prognosis of more than 2 months
4) 20 years or older
5) Cases with informed consent after sufficient explanation from physician and patient's understanding
6) 2 or less in ECOG performance status

Key exclusion criteria

1) Massive ascites
2) Cases with serious complications in other organs
3) Hilar biliary obstruction
4) Altered anatomy following Billroth-II or Roux-en-Y gastrectomy
5) Case in which ERCP is difficult to perform
6) Duodenal stenosis on the anal side more than the duodenal papilla (cases improved with the duodenal stent can be enrolled)
7) Case in which the physician judged inappropriate for some reason

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Shinpei
Middle name
Last name Shinpei

Organization

Teikyo University School of medicine University Mizonokuchi Hospital

Division name

Dept of Gastroenterology

Zip code

213-8507

Address

5-1-1, Futago, Takatsu-ku, Kawasaki city, Kanagawa

TEL

044-844-3333

Email

sinpesan@gmail.com


Public contact

Name of contact person

1st name Shinpei
Middle name
Last name Shinpei

Organization

Teikyo University School of medicine University Mizonokuchi Hospital

Division name

Dept of Gastroenterology

Zip code

213-8507

Address

5-1-1, Futago, Takatsu-ku, Kawasaki city, Kanagawa

TEL

044-844-3333

Homepage URL


Email

sinpesan@gmail.com


Sponsor or person

Institute

Dept of Gastroenterology, Teikyo University School of medicine University Mizonokuchi Hospital

Institute

Department

Personal name



Funding Source

Organization

Dept of Gastroenterology, Teikyo University School of medicine University Mizonokuchi Hospital

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Teikyo University Ethics Committee Secretariat

Address

2-11-1, Kaga, Itabashi-ku, Tokyo

Tel

03-3964-7256

Email

turb-office@teikyo-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

帝京大学医学部附属溝口病院(神奈川県)


Other administrative information

Date of disclosure of the study information

2020 Year 10 Month 11 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2017 Year 12 Month 01 Day

Date of IRB

2017 Year 09 Month 15 Day

Anticipated trial start date

2017 Year 12 Month 01 Day

Last follow-up date

2020 Year 12 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

None


Management information

Registered date

2020 Year 10 Month 11 Day

Last modified on

2020 Year 10 Month 11 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034711


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name